Art Exhibit to Honor a Friendship and Raise Funds for AIM
…subtype of superficial spreading melanoma and the most aggressive form of the disease. Unlike other melanomas that tend to grow…
Art Exhibit to Honor a Friendship and Raise Funds for AIM
…subtype of superficial spreading melanoma and the most aggressive form of the disease. Unlike other melanomas that tend to grow…
,
,
A Letter From Our Vice President | May 2021
…knew that my husband had been a Stage III melanoma patient and that was why she was interested in talking…
,
President’s Letter | January 2022
…melanoma. Kimmtrak is the first and only FDA-approved therapy for the treatment of unresectable or metastatic uveal melanoma (mUM). mUM…
,
I’ve Been Diagnosed With Melanoma…Now What? PART I with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
The test results are back. You’ve talked to the doctor and learned you have melanoma. Whether it’s your first or…
,
Everything Coming up Rosy is not a Health Tune
…patients with rosacea had an increase of nonmelanoma skin cancer, the odds ratio was 5.55, which means the odds were…
,
The FDA Said No — Now We Need Your Voice
…decision. Share your story with us by filling out this form. Your voice could help drive change for the melanoma…
,
,
Living Through TIL Therapy: A Personal Story
…was referred to a dermatologist. Biopsies proved why the spot hadn’t faded with creams: Michael had skin cancer, specifically acral…
,
“A Celebration of Friendship” Solo Exhibit Shares Heartfelt Story While Raising Funds for AIM at Melanoma Foundation
…show after commission to AIM at Melanoma Foundation. The AIM at Melanoma Foundation (AIM) is the largest non-profit international organization…
,
,
Making the Cut For Melanoma: A Mom’s Motivation
…fundraiser in honor of all melanoma survivors and for those who lost their fight. Traci chose to donate to AIM…
,
,
Sun Safety and Psychological Challenges For Melanoma Survivors
…primarily in adult medicine and oncology with a focus on skin cancers with melanoma, she also serves as a sub-investigator…
,
Recent Posts
May. 21, 2026
Webinar: Post-ASCO Melanoma Research Update
May. 04, 2026
Melanoma Monday: Every Day. Everywhere.
Apr. 27, 2026
Lilly Pulitzer and AIM at Melanoma Partner for 5th Annual Community Giving Event
Apr. 19, 2026
KIMMTRAK doubles the likelihood of being alive at five years for firstline HLA-A*02:01+ patients with metastatic uveal melanoma
Apr. 10, 2026